MIAMI, FL – June 30, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced the launch of ClearMetrX, the Company’s first wholly-owned data analytics company with services designed to support health care organizations across the country.

MIAMI, FL – June 22, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for May 2020, including strong year-over-year growth in the face of continued intense downward pressure from tightening provider prescription demand, with strong execution, patient growth, and expanding Federally Qualified Health Centers (FQHCs) dispensing fees driving robust systemwide performance.

MIAMI, FL – June 22, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, has engaged Daszkal Bolton LLP as its new independent public accounting firm as it undertakes efforts to transition to reporting under the Exchange Act Reporting requirements.

MIAMI, FL– June 12, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”),a personalized healthcare services and technology company, is pleased to issue the following progress update as the Company prepares for an exciting second half of 2020.

MIAMI, FL– June 1, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”),a personalized healthcare services and technology company, is pleased to announce that the Company has selected Atlas Construction and Management LLC (the “Contractor” or “Atlas”)for the construction project at 400 Ansin Blvd in Hallandale Beach, FL.

MIAMI, FL – May 20, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for April 2020, which represented a very challenging context given clear COVID-19 factors, but also featured strong growth in net sales, prescriptions filled, 340B income, and total patients served, as well as the nationwide launch of our new e-commerce platform and antibody testing program.

Join our CEO, Shital Mars, as she answers the most relevant questions related to COVID-19 regarding reopening, testing, second wave, and more.

MIAMI, FL – May 18, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to report financial results for the quarter ended March 31, 2020, which featured very strong revenue growth, especially considering the unique operating conditions during February and March due to the SARS-CoV-2 global pandemic health crisis. During the associated earnings call, management outlined specific competitive advantages and new initiatives positioning the Company for strong growth across all major metrics throughout 2020.

MIAMI, FL – May 14, 2020 – Progressive CareInc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is very pleased to announce that the company has obtained the immediate capacity to market and distribute rapid-results antibody test kits (COVID-19 IgG/IgM) registered through the FDA under its emergency Use Authorization (“EUA”) guidelines for conducting SARS-CoV-2antibody presence and COVID-19 infection diagnosis testing.

‍MIAMI, May 11th 2020 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Friday, May 15th, 2020.